Propanc Biopharma Inc.
PPCB | NASDAQ
$1.92
+$0.08 (+4.35%)
Nov 2, 2026, 10:34 AM ET · Market open
TTM Period Ending | Q4 2026 Jun 30, 2026 | Q3 2026 Mar 31, 2026 | Q2 2026 Dec 31, 2025 | Q1 2026 Sep 30, 2025 | Q4 2025 Jun 30, 2025 | Q3 2025 Mar 31, 2025 | Q2 2025 Dec 31, 2024 | Q1 2025 Sep 30, 2024 | Q4 2024 Jun 30, 2024 | Q3 2024 Mar 31, 2024 | Q2 2024 Dec 31, 2023 | Q1 2024 Sep 30, 2023 | Q4 2023 Jun 30, 2023 | Q3 2023 Mar 31, 2023 | Q2 2023 Dec 31, 2022 | Q1 2023 Sep 30, 2022 | Q4 2022 Jun 30, 2022 | Q3 2022 Mar 31, 2022 | Q2 2022 Dec 31, 2021 | Q1 2022 Sep 30, 2021 | Q4 2021 Jun 30, 2021 | Q3 2021 Mar 31, 2021 | Q2 2021 Dec 31, 2020 | Q1 2021 Sep 30, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 438.06K | 855.28K | 855.28K | 855.28K | 423.37K | 578.98K | 1.18M | 1.18M | 1.17M | 600.7K | 2.03K | 2.06K | 2.06K | 1.99K | 2.08K | 2.15K | 2.28K |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -438.06K | -855.28K | -855.28K | -855.28K | -423.37K | -578.98K | -1.18M | -1.18M | -1.17M | -600.7K | -2.03K | -2.06K | -2.06K | -1.99K | -2.08K | -2.15K | -2.28K |
Operating Income | -18.19M | -18.37M | -65.1M | -61.66M | -57.28M | -53.89M | -1.18M | -1.41M | -1.54M | -1.49M | -1.45M | -1.62M | -1.78M | -2.17M | -2.28M | -2.08M | -1.99M | -2.12M | -2.04M | -1.92M | -1.81M | -1.68M | -1.86M | -2.97M |
Interest Income | 161 | 76 | 64 | 27 | 9 | 2 | 28 | 44 | 60 | 69 | 50 | 51 | 36 | 5.64K | 5.63K | 5.62K | 5.61K | n/a | n/a | 1 | 1 | 804 | 941 | 943 |
Pretax Income | -18.86M | -18.36M | -66.07M | -63.41M | -58.92M | -55.21M | -1.67M | -1.95M | -1.95M | -2.34M | -2.62M | -2.52M | -2.79M | -2.95M | -2.6M | -2.84M | -2.71M | -2.59M | -2.66M | -2.2M | -2.14M | -154.88K | -2.24M | -3.7M |
Net Income | -18.86M | -18.36M | -66.07M | -63.41M | -58.92M | -55.21M | -1.67M | -1.82M | -1.82M | -2.21M | -2.49M | -2.39M | -2.66M | -2.82M | -2.47M | -2.78M | -2.66M | -2.53M | -2.49M | -2.09M | -2.03M | -42.94K | -2.21M | -3.67M |
Selling & General & Admin | 17.56M | 18.07M | 64.91M | 61.44M | 57.05M | 53.67M | 951K | 792K | 562.93K | 552.73K | 517.5K | 1.04M | 1.04M | 847.17K | 978.27K | 803.51K | 1.24M | 1.88M | 1.82M | 1.69M | 1.58M | 1.47M | 1.64M | 2.8M |
Research & Development | 625.48K | 303.34K | 187.78K | 222.21K | 223.72K | 222.59K | 233.94K | 179.55K | 117.84K | 71.14K | 71.72K | 146.59K | 146.59K | 140.9K | 125.27K | 101.15K | 147.7K | 232.76K | 227.25K | 226.66K | 230.96K | 202.99K | 215.59K | 165.46K |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 6.6K | 6.6K | 6.6K | 6.6K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 18.19M | 18.37M | 65.1M | 61.66M | 57.28M | 53.89M | 1.18M | 971.56K | 680.77K | 630.47K | 595.81K | 1.2M | 1.2M | 988.06K | 1.1M | 904.65K | 1.39M | 2.12M | 2.04M | 1.91M | 1.81M | 1.68M | 1.86M | 2.97M |
Interest Expense | 430.54K | 657.42K | 723.19K | 783.18K | 563.76K | 399.22K | 428.32K | 573.84K | 665.84K | 690.08K | 714.15K | 548.3K | 532.82K | 532.24K | 542.41K | 621.7K | 568.8K | 484.57K | 420.1K | 400.03K | 449.46K | 662.29K | 944.19K | 1.23M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 8.71K | 15.95K | 15.95K | 15.95K | 7.24K | 6.96K |
Cost & Expenses | 18.19M | 18.37M | 65.1M | 61.66M | 57.28M | 53.89M | 1.18M | 1.41M | 1.54M | 1.49M | 1.45M | 1.62M | 1.78M | 2.17M | 2.28M | 2.08M | 1.99M | 2.12M | 2.04M | 1.92M | 1.81M | 1.68M | 1.86M | 2.97M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | -237 | -512 | -129.13K | -129.13K | -127.7K | -129.14K | -129.84K | -129.84K | -130.76K | -128.84K | -54.98K | -54.98K | -56.39K | -168.88K | -113.42K | -113.42K | -111.94K | -25.98K | -25.83K |
Shares Outstanding (Basic) | 112.37K | 63.89K | 53.44K | 49.33K | 15.87K | 17.3K | 534 | 49 | 164.03 | 73 | 1.59 | 0.73 | 1.74M | 0.03 | 0.05 | 0.03 | 68.22M | 2.65K | 0 | 0 | 562 | 0 | 36 | 0 |
Shares Outstanding (Diluted) | 112.37K | 63.89K | 53.44K | 49.33K | 15.87K | 17.3K | 534 | 49 | 164.03 | 73 | 1.59 | 0.73 | 1.74M | 0.03 | 0.05 | 0.03 | 68.22M | 2.65K | 0 | 0 | 562 | 0 | 36 | 0 |
EPS (Basic) | -313.61 | -529.42 | -3.55K | -4.28K | -11.38K | -13.31K | -17.61K | -406.69K | -1.07M | -1.07M | -31.62M | -41.77M | -72.98M | -72.98M | -42.42M | -381.59M | -684.34M | -684.34M | -7.68B | -7.33B | -17.68B | -17.68B | -5.24T | -24T |
EPS (Diluted) | -313.61 | -529.42 | -3.55K | -4.28K | -11.38K | -13.31K | -17.61K | -406.69K | -1.07M | -1.07M | -31.62M | -41.77M | -72.98M | -72.98M | -42.42M | -381.59M | -684.34M | -684.34M | -7.68B | -7.33B | -17.68B | -17.68B | -5.24T | -24T |
EBITDA | -18.41M | -17.68M | -65.32M | -62.61M | -58.34M | -54.79M | -1.22M | -1.36M | -1.27M | -1.64M | -1.91M | -1.97M | -2.25M | -2.41M | -2.05M | -2.22M | -2.14M | -2.1M | -2.23M | -1.8M | -1.69M | 509.5K | -1.29M | -2.47M |
EBIT | -18.43M | -17.7M | -65.34M | -62.62M | -58.36M | -54.81M | -1.24M | -1.38M | -1.28M | -1.65M | -1.91M | -1.98M | -2.26M | -2.42M | -2.06M | -2.22M | -2.14M | -2.1M | -2.24M | -1.8M | -1.69M | 507.41K | -1.29M | -2.47M |
Depreciation & Amortization | 22.7K | 21.56K | 20.06K | 18.36K | 20.19K | 20.72K | 20.4K | 16.19K | 10.79K | 5.34K | 1.02K | 7.05K | 7.39K | 7.56K | 7.6K | 1.96K | 1.99K | 2.03K | 2.06K | 2.06K | 1.99K | 2.08K | 2.15K | 2.28K |
Add to Watchlist
Select watchlists to add or remove PPCB